272 related articles for article (PubMed ID: 9489377)
1. [Testing basic visual functions in the evaluation of extrapyramidal side effects of antipsychotic agents].
Kéri S; Antal A; Szekeres G; Szendi I; Kovács Z; Janka Z; Benedek G
Orv Hetil; 1998 Feb; 139(5):235-8. PubMed ID: 9489377
[TBL] [Abstract][Full Text] [Related]
2. Use of novel antipsychotic drugs.
Raleigh F
Pharmacotherapy; 1996; 16(6 Pt 2):160S-165S; discussion 166S-168S. PubMed ID: 8948000
[TBL] [Abstract][Full Text] [Related]
3. The impact of neuroleptic dosage and extrapyramidal side effects on schizophrenic basic symptoms.
Moritz S; Krausz M; Gottwalz E; Andresen B
Compr Psychiatry; 2000; 41(4):284-8. PubMed ID: 10929797
[TBL] [Abstract][Full Text] [Related]
4. The continuing problem of extrapyramidal symptoms: strategies for avoidance and effective treatment.
Gerlach J
J Clin Psychiatry; 1999; 60 Suppl 23():20-4. PubMed ID: 10625196
[TBL] [Abstract][Full Text] [Related]
5. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
Honer WG; Kopala LC; Rabinowitz J
J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513
[TBL] [Abstract][Full Text] [Related]
6. Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medication.
Greenbaum L; Strous RD; Kanyas K; Merbl Y; Horowitz A; Karni O; Katz E; Kotler M; Olender T; Deshpande SN; Lancet D; Ben-Asher E; Lerer B
Pharmacogenet Genomics; 2007 Jul; 17(7):519-28. PubMed ID: 17558307
[TBL] [Abstract][Full Text] [Related]
7. [Occurrence of tardive extrapyramidal symptoms in schizophrenic patients undergoing prolonged neuroleptic treatment].
Rybakowski J; Jaracz J; Lis B; Milewska G; Lezańska M
Psychiatr Pol; 1979; 13(5):479-85. PubMed ID: 42096
[No Abstract] [Full Text] [Related]
8. [Non-extrapyramidal motor side-effects in long-term therapy with neuroleptics: an analysis of 99 patients].
Ginzel I; Hilger E; Barnas C
Wien Klin Wochenschr; 2002 Jan; 114(1-2):38-43. PubMed ID: 12407934
[TBL] [Abstract][Full Text] [Related]
9. Kinematical analysis of motor function in schizophrenic patients: a possibility to separate negative symptoms from extrapyramidal dysfunction induced by neuroleptics?
Henkel V; Mergl R; Schäfer M; Rujescu D; Möller HJ; Hegerl U
Pharmacopsychiatry; 2004 May; 37(3):110-8. PubMed ID: 15138894
[TBL] [Abstract][Full Text] [Related]
10. Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics.
Strejilevich SA; Palatnik A; Avila R; Bustin J; Cassone J; Figueroa S; Gimenez M; de Erausquin GA
Psychiatry Res; 2005 Feb; 133(2-3):277-80. PubMed ID: 15741003
[TBL] [Abstract][Full Text] [Related]
11. Some adverse effects of antipsychotics: prevention and treatment.
Lader M
J Clin Psychiatry; 1999; 60 Suppl 12():18-21. PubMed ID: 10372605
[TBL] [Abstract][Full Text] [Related]
12. [Acute-onset extrapyramidal syndromes caused by drugs].
Montoya Cabrera MA; López Martín G; Baca Rodríguez LC; Porcayo Vergara F; Hernández Zamora A; Juárez Aragón G
Bol Med Hosp Infant Mex; 1981; 38(4):607-15. PubMed ID: 6117295
[TBL] [Abstract][Full Text] [Related]
13. Prolactin response and extrapyramidal side effects during propranolol and neuroleptic drugs treatment in chronic schizophrenic patients.
Elizur A; Segal S; Yeret A; Ben-David M
Isr Ann Psychiatr Relat Discip; 1979 Dec; 17(4):318-27. PubMed ID: 44877
[No Abstract] [Full Text] [Related]
14. Serum neuroleptic levels and extrapyramidal side effects in patients treated with amoxapine.
Gaffney GR; Tune LE
J Clin Psychiatry; 1985 Oct; 46(10):428-9. PubMed ID: 2864332
[TBL] [Abstract][Full Text] [Related]
15. Novel pharmacological approaches to the treatment of schizophrenia.
Fink-Jensen A
Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
[TBL] [Abstract][Full Text] [Related]
16. Extrapyramidal side effects: a historical perspective.
Rifkin A
J Clin Psychiatry; 1987 Sep; 48 Suppl():3-6. PubMed ID: 2887555
[TBL] [Abstract][Full Text] [Related]
17. The purely neuroleptic effects and its relation to the "neuroleptic threshold".
Haase HJ
Acta Psychiatr Belg; 1978; 78(1):19-36. PubMed ID: 645405
[TBL] [Abstract][Full Text] [Related]
18. Motoric neurological soft signs and psychopathological symptoms in schizophrenic psychoses.
Jahn T; Hubmann W; Karr M; Mohr F; Schlenker R; Heidenreich T; Cohen R; Schröder J
Psychiatry Res; 2006 Jun; 142(2-3):191-9. PubMed ID: 16650902
[TBL] [Abstract][Full Text] [Related]
19. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
20. Fluphenazine-induced extrapyramidal side effects in a horse.
Brashier M
Vet Clin North Am Equine Pract; 2006 Apr; 22(1):e37-45. PubMed ID: 16627093
[No Abstract] [Full Text] [Related]
[Next] [New Search]
